当前位置:主页 >> 专业解读 >> 安全事件解读 >> 欧盟评估一种异麦芽糖合酶的安全性

欧盟评估一种异麦芽糖合酶的安全性

放大字体  缩小字体 发布日期:2021-04-12  来源:食品伙伴网  作者:泽夕
中共质检总局党组关于巡视整改情况的通报用微信扫描二维码 分享至好友和朋友圈
核心提示:2021年4月9日,欧盟食品安全局就一种食品酶制剂异麦芽糖合酶(isomaltulose synthase)的安全性评价发布意见。
   食品伙伴网讯  2021年4月9日,欧盟食品安全局就一种食品酶制剂异麦芽糖合酶(isomaltulose synthase)的安全性评价发布意见。
 
  据了解,这种食品酶制剂是由Serratia plymuthica strain Z12A生产的。经过评估,专家小组得出结论,该食品酶制剂在预期的使用条件下不会引起安全问题。部分原文报道如下:
 
  The food enzyme isomaltulose synthase (sucrose glucosylmutase; EC 5.4.99.11) is produced with Serratia plymuthica strain Z12A by BENEO‐Palatinit GmbH. The food enzyme is used only in the form of an immobilised preparation of non‐viable cells for the production of isomaltulose. Residual amounts of total organic solids (TOS) are removed by the purification steps applied during the production of isomaltulose consequently, dietary exposure was not calculated. Genotoxicity tests did not indicate safety concern. The systemic toxicity was assessed by means of a repeated dose 90‐day oral toxicity study in rats. The Panel identified a no observed adverse effect level of 1,011 mg TOS/kg body weight (bw) per day, the highest dose tested. Similarity of the amino acid sequence of the enzyme to those of known allergens was searched and no match was found. The Panel considered that, under the intended conditions of use, the risk of allergic sensitisation and elicitation reactions by dietary exposure cannot be excluded, but the likelihood of such reactions to occur is considered to be low. based on the data provided, the use of an immobilised food enzyme and the removal of TOS during the production of isomaltulose the Panel concluded that this food enzyme preparation does not give rise to safety concerns under the intended conditions of use.
 
 
 
推荐产品&服务MORE>>